化合物BEBT-908 T16529
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mg | 1235449-52-1 | ¥3,850.00 | 询底价 |
5 mg | 1235449-52-1 | ¥2,560.00 | 询底价 |
500 mg | 1235449-52-1 | ¥22,800.00 | 询底价 |
25 mg | 1235449-52-1 | ¥6,190.00 | 询底价 |
1 mL | 1235449-52-1 | ¥2,960.00 | 询底价 |
100 mg | 1235449-52-1 | ¥11,300.00 | 询底价 |
1 mg | 1235449-52-1 | ¥987.00 | 询底价 |
2 mg | 1235449-52-1 | ¥1,490.00 | 询底价 |
50 mg | 1235449-52-1 | ¥8,520.00 | 询底价 |
Product Introduction
Bioactivity
英文名: BEBT-908
描述: BEBT-908 (PI3Kα inhibitor 1) 是一种选择性的PI3Kα抑制剂(IC50<0.1 μM),也抑制 HDAC (0.1 μM≤IC50≤1 μM)。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 35 mg/mL (68.96 mM)
关键字: PI3Ka inhibitor 1 | Inhibitor | MDK-9521 | BEBT908 | BEBT 908 | MDK 9521 | BEBT-908 | PI3K | PI3Kalpha inhibitor 1 | inhibit | Phosphoinositide 3-kinase
相关产品: Pilaralisib analogue | Dalbergioidin | Selective PI3Kδ Inhibitor 1 | IHMT-PI3K-455 | (2S,3R,4S)-4-Hydroxyisoleucine | Vps34-IN-2 | CAL-130 | FD274 | HS-173 | Serabelisib
相关库: Anti-Prostate Cancer Compound Library | Oxidation-Reduction Compound Library | Anti-Cancer Compound Library | NF-κB Signaling Compound Library | Inhibitor Library | Kinase Inhibitor Library | Anti-Obesity Compound Library | Anti-Pancreatic Cancer Compound Library | Metabolism Compound Library | Reprogramming Compound Library
化合物BEBT-908 T16529信息由TargetMol中国为您提供,如您想了解更多关于化合物BEBT-908 T16529报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途